CARotid plaqUe StabilizatiOn and Regression With Evolocumab.

NCT04730973 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

130

Enrollment

OTHER

Sponsor class

Conditions

Carotid Artery Disease

Interventions

DRUG: Evolocumab
OTHER: lipid-lowering therapy (LLT)

Sponsor

Azienda Ospedaliera Ordine Mauriziano di Torino